![](/img/cover-not-exists.png)
5.50 CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Exhibits CLL Antitumor Activity
Renee Prins, Luke B. Fletcher, Russell T. Burke, Marc M. Loriaux, Brian J. Druker, Stephen E. SpurgeonVolume:
11
Year:
2011
Language:
english
DOI:
10.1016/j.clml.2011.09.204
File:
PDF, 97 KB
english, 2011